Identification of claudin-4 as a marker highly overexpressed in both primary and metastatic prostate cancer.
about
Claudin 4 Is differentially expressed between ovarian cancer subtypes and plays a role in spheroid formation.Prostate-based biofluids for the detection of prostate cancer: A comparative study of the diagnostic performance of cell-sourced RNA biomarkers.Markers for detection of prostate cancer.Claudins and alveolar epithelial barrier function in the lungThe role of epithelial tight junctions involved in pathogen infections.Genome-wide analysis of androgen receptor binding and gene regulation in two CWR22-derived prostate cancer cell lines.Roles of the first-generation claudin binder, Clostridium perfringens enterotoxin, in the diagnosis and claudin-targeted treatment of epithelium-derived cancers.The role of claudins in cancer metastasis.Claudin proteins, outside-in signaling, and carcinogenesis.Claudin-4-targeted therapy using Clostridium perfringens enterotoxin for prostate cancer.Correlation between Claudins Expression and Prognostic Factors in Prostate Cancer.Non-coding RNAs participate in the regulatory network of CLDN4 via ceRNA mediated miRNA evasion.Immunohistochemical profiles of claudin-3 in primary and metastatic prostatic adenocarcinoma.Prognostic potential of ERG (ETS-related gene) expression in prostatic adenocarcinoma.Imaging of Claudin-4 in Pancreatic Ductal Adenocarcinoma Using a Radiolabelled Anti-Claudin-4 Monoclonal Antibody.The prognostic role of claudins in head and neck squamous cell carcinomas.Enhanced cellular uptake and tumor penetration of nanoparticles by imprinting the "hidden" part of membrane receptors for targeted drug delivery.Prognostic Significance of Lymphatic Vessel Density Detected by D2-40 and Its Relation to Claudin-4 Expression in Prostatic Adenocarcinoma.Diagnostic performance of expression of PCA3, Hepsin and miR biomarkers inejaculate in combination with serum PSA for the detection of prostate cancer
P2860
Q34875061-E382AD20-A41F-4DA2-98C3-398BEA9F7AEEQ37273884-03F18784-648C-4537-B71B-CFE4BAECF4FDQ37328403-0101FB45-AFBC-46C8-90C5-76845FA4B6E2Q38016500-E43E1BF0-8C53-4D6C-B9AD-729DE0122D9AQ38223244-38275CB3-D101-4EEF-96D9-ECA1E4053DB8Q38342443-8E3E7B0D-2CB4-4440-8173-593BDC241389Q38821198-C03077A1-93A2-43E9-920F-AE0F01869635Q38927656-BDBC394B-7AD0-43D1-B00A-8A4358D3819EQ39042347-B5265A2F-4915-48C3-88A2-39F1842395E0Q39527898-CFF91194-16CB-4BA5-AFA9-11A0217FDCB2Q40164661-65BAB294-0AEE-40DE-ABF2-E72C8D2EE1B0Q41447334-C129E3A8-AD01-48B4-938F-752C53235487Q42590043-F219EB0B-B76D-4ED1-B869-E19FBCE16F30Q43117102-D3D43161-1125-45DA-A5B0-A138AFC9E15BQ47903216-C3B46559-1861-4881-8AC3-C67726E461E8Q48002827-572A624C-B9AD-499C-A34A-76A74D3751AFQ50003210-17D04EFC-8E6C-4D57-952D-4262F7EBD80EQ53786406-71413A93-1593-4BA2-9E02-F59274F400B1Q57230540-DCC02DC2-C153-43AC-B131-D8DFE31AC7DC
P2860
Identification of claudin-4 as a marker highly overexpressed in both primary and metastatic prostate cancer.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Identification of claudin-4 as ...... nd metastatic prostate cancer.
@en
type
label
Identification of claudin-4 as ...... nd metastatic prostate cancer.
@en
prefLabel
Identification of claudin-4 as ...... nd metastatic prostate cancer.
@en
P2093
P2860
P356
P1476
Identification of claudin-4 as ...... nd metastatic prostate cancer.
@en
P2093
K A Landers
M J Burger
R A Gardiner
P2860
P2888
P304
P356
10.1038/SJ.BJC.6604486
P407
P577
2008-07-22T00:00:00Z